News

C&R Research (CEO Moon-Tae Yoon) announced the commencement of pre-registration for a free clinical trial symposium for pharmaceutical industry professionals,…

C&R Research and 'EYEBIOKOREA' signed an MOU to 'Efficiently manage clinical trials for ophthalmic diseases and enhance global clinical competitiveness'.…

'New things, always by us!' made C&R Research No.1 CRO in South Korea.   Byungjin Ahn, President of C&R Research,…

C&R Research and 'Chonnam National University Hwasun Hospital' signed an MOU to 'Strengthen Data Utilization in Clinical Research'.   Through…

C&R Research successfully carried out EMA approval for the Phase 3 IND clinical trial of ‘EYELEA’ Biosimilar with Rophibio, Inc.…

C&R Research and GC Cell signed an MOU to strengthen global clinical competitiveness and sales power.   Through this business…

C&R Research (CEO Moon-Tae Yoon) announced about conducting a Phase 1 clinical trial for 'Non-Small Cell Lung Cancer' of ONCOBIX…

C&R Research successfully carried out US FDA approval for the Phase 3 IND clinical trial of 'EYELEA' Biosimilar with Rophibio,…

C&R Research (CEO Moon-Tae Yoon) successfully carried out the US FDA medical device 510(k) approval work, expanding business scope to…

C&R Research, a contract research organization (CRO) is undergoing a complete overhaul of its clinical data collection method. They are…